Etelcalcetide

From WikiMD.org
Jump to navigation Jump to search

Etelcalcetide

Etelcalcetide (pronounced as et-el-kal-se-tide) is a medication used in the treatment of secondary hyperparathyroidism associated with chronic kidney disease.

Etymology

The name "Etelcalcetide" is derived from the chemical structure of the drug. "Etel" is a prefix used in pharmacology to denote a drug's synthetic origin, while "calcet" refers to the drug's action on calcium levels in the body, and "tide" is a common suffix for peptides, indicating the drug's peptide structure.

Usage

Etelcalcetide is used to lower parathyroid hormone (PTH) levels in adults with chronic kidney disease who are on dialysis. It works by binding to and activating the calcium-sensing receptor on the parathyroid gland, which decreases PTH secretion, serum calcium levels, and phosphate levels.

Dosage and Administration

Etelcalcetide is administered intravenously at the end of each hemodialysis session. The dosage is individualized and adjusted based on the patient's parathyroid hormone levels.

Side Effects

Common side effects of Etelcalcetide include nausea, vomiting, diarrhea, and hypocalcemia (low calcium levels). Severe hypocalcemia can lead to serious complications such as arrhythmia and seizures.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski